A synthetic biology approach to engineering circuits in immune cells

被引:3
|
作者
Hoces, Daniel [1 ,2 ]
Blanco, Jesus Miguens [1 ,2 ]
Hernandez-Lopez, Rogelio A. [1 ,2 ,3 ,4 ]
机构
[1] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Genet, Stanford, CA 94305 USA
[3] Stanford Canc Inst, Stanford, CA USA
[4] Chan Zuckerberg Biohub San Francisco, San Francisco, CA USA
关键词
immunoengineering; immunology; synthetic biology; synthetic circuits; CAR-T-CELLS; NETWORK MOTIFS; B-CELL; TUMOR RECOGNITION; DENDRITIC CELLS; ULTRASENSITIVITY; RESPONSES; OSCILLATIONS; EXHAUSTION; PRINCIPLES;
D O I
10.1111/imr.13244
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A synthetic circuit in a biological system involves the designed assembly of genetic elements, biomolecules, or cells to create a defined function. These circuits are central in synthetic biology, enabling the reprogramming of cellular behavior and the engineering of cells with customized responses. In cancer therapeutics, engineering T cells with circuits have the potential to overcome the challenges of current approaches, for example, by allowing specific recognition and killing of cancer cells. Recent advances also facilitate engineering integrated circuits for the controlled release of therapeutic molecules at specified locations, for example, in a solid tumor. In this review, we discuss recent strategies and applications of synthetic receptor circuits aimed at enhancing immune cell functions for cancer immunotherapy. We begin by introducing the concept of circuits in networks at the molecular and cellular scales and provide an analysis of the development and implementation of several synthetic circuits in T cells that have the goal to overcome current challenges in cancer immunotherapy. These include specific targeting of cancer cells, increased T-cell proliferation, and persistence in the tumor microenvironment. By harnessing the power of synthetic biology, and the characteristics of certain circuit architectures, it is now possible to engineer a new generation of immune cells that recognize cancer cells, while minimizing off-target toxicities. We specifically discuss T-cell circuits for antigen density sensing. These circuits allow targeting of solid tumors that share antigens with normal tissues. Additionally, we explore designs for synthetic circuits that could control T-cell differentiation or T-cell fate as well as the concept of synthetic multicellular circuits that leverage cellular communication and division of labor to achieve improved therapeutic efficacy. As our understanding of cell biology expands and novel tools for genome, protein, and cell engineering are developed, we anticipate further innovative approaches to emerge in the design and engineering of circuits in immune cells.
引用
收藏
页码:120 / 137
页数:18
相关论文
共 50 条
  • [41] Reconstitution of an Ultradian Oscillator in Mammalian Cells by a Synthetic Biology Approach
    Santorelli, Marco
    Perna, Daniela
    Isomura, Akihiro
    Garzilli, Immacolata
    Annunziata, Francesco
    Postiglione, Lorena
    Tumaini, Barbara
    Kageyama, Ryoichiro
    di Bernardo, Diego
    ACS SYNTHETIC BIOLOGY, 2018, 7 (05): : 1447 - 1455
  • [42] PREditOR: a synthetic biology approach to removing heterochromatin from cells
    Molina, Oscar
    Carmena, Mar
    Maudlin, Isabella E.
    Earnshaw, William C.
    CHROMOSOME RESEARCH, 2016, 24 (04) : 495 - 509
  • [43] PREditOR: a synthetic biology approach to removing heterochromatin from cells
    Oscar Molina
    Mar Carmena
    Isabella E. Maudlin
    William C. Earnshaw
    Chromosome Research, 2016, 24 : 495 - 509
  • [44] Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells
    Mansouri, Maysam
    Fussenegger, Martin
    PROTEIN & CELL, 2022, 13 (07) : 476 - 489
  • [45] Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells
    Maysam Mansouri
    Martin Fussenegger
    Protein & Cell, 2022, 13 (07) : 476 - 489
  • [46] Engineering living therapeutics with synthetic biology
    Cubillos-Ruiz, Andres
    Guo, Tingxi
    Sokolovska, Anna
    Miller, Paul F.
    Collins, James J.
    Lu, Timothy K.
    Lora, Jose M.
    NATURE REVIEWS DRUG DISCOVERY, 2021, 20 (12) : 941 - 960
  • [47] Engineering living therapeutics with synthetic biology
    Andres Cubillos-Ruiz
    Tingxi Guo
    Anna Sokolovska
    Paul F. Miller
    James J. Collins
    Timothy K. Lu
    Jose M. Lora
    Nature Reviews Drug Discovery, 2021, 20 : 941 - 960
  • [48] SYNTHETIC BIOLOGY Engineering a blue rose
    Peplow, Mark
    CHEMICAL & ENGINEERING NEWS, 2018, 96 (40) : 9 - 9
  • [49] Engineering the Future through Synthetic Biology
    Tae Seok Moon
    Biotechnology and Bioprocess Engineering, 2023, 28 : 889 - 891
  • [50] Synthetic biology meets tissue engineering
    Davies, Jamie A.
    Cachat, Elise
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2016, 44 : 696 - 701